Treatment-Resistant Depression · Hayward, CA

By the time most people sit down for a treatment-resistant depression consult, they are tired of starting over. They have done the SSRI. They added a second one, or switched to an SNRI, or layered on bupropion. Somewhere in there a provider mentioned augmentation, and the word landed like a sigh. What they are dreading, walking into the next appointment, is that it will be the same thing again: someone glances at the chart, reaches for the prescription pad, and picks the next pill more or less at random.

It should not feel like that. When two reasonable medications have not done enough, the right next step is not a faster guess. It is a slower look. A good TRD consult is a structured re-evaluation, and it is trying to answer a small set of practical questions before anyone writes anything: What has actually been tried? Did those treatments get a fair test? Is something else keeping the depression stuck? And is it time to move past the usual medication path entirely?

This piece walks through what that appointment is supposed to do, in the order it usually happens, so you can recognize a thorough evaluation when you are in one and ask for it when you are not.

“Treatment-resistant” doesn’t always mean what it sounds like

The label gets used loosely, so it helps to know what it means clinically. Treatment-resistant depression is usually defined as depression that has not responded adequately to at least two antidepressant trials, given that each trial reached an adequate dose, ran for an adequate length of time, and was actually taken as prescribed.^[2] A 2023 review in World Psychiatry notes that this two-trial definition is the one adopted by both the FDA and the European regulators, and that at least 30% of people with depression end up meeting it.^[1] So if you are here, you are not an unusual case. You are part of a very large group.

Here is the part the label hides. That same review points out that a meaningful share of what looks like treatment resistance is actually pseudo-resistance: depression that was never given a fair shot, because the dose was too low, the trial was too short, the medication was stopped early, or it was taken inconsistently.^[1] That distinction is not academic. It changes the entire plan. Depression that genuinely did not respond to a full, adequate trial points one direction. Depression that was under-treated points somewhere else completely. The whole first half of a good consult exists to tell those two apart.

1. They review what you already tried

The appointment usually opens with your treatment history, and the questions can feel repetitive if you have answered them before. They are not busywork. Your provider is reconstructing each past trial to see whether it was a real test or only a partial one.

Expect to be asked: which medications you have taken, what dose you reached, how long you stayed on each one, whether you took it consistently, what improved even slightly, what side effects made it hard, and why you ultimately stopped. The reason these matter is mechanical. Stopping a medication after four days because it made you nauseated tells a completely different story than taking it for eight weeks at a therapeutic dose and feeling nothing. The first is an unfinished trial. The second is a genuine nonresponse. Only one of them counts as evidence that the medication failed you.

You do not need a perfect record to do this well. Even a rough timeline, scratched out on the back of an envelope, gives your provider far more to work with than memory alone. A little preparation here changes the quality of the entire visit.

2. They separate partial response from no response

Not every “failed” treatment failed the same way, and the difference carries real information. If a medication nudged your sleep, steadied your energy, or thinned out the crying spells while leaving you still depressed, that is a partial response. It tells your provider that the treatment found something to grab onto, and that the next move might be to build on it rather than abandon it.

If nothing moved at all, across an adequate trial, that is a different signal. It may point toward switching strategies entirely, taking a harder look at the diagnosis, or considering a treatment that works through a different mechanism. The point of going back through your history is not the simple yes-or-no of whether a treatment “worked.” It is what kind of information each attempt left behind. A consult that treats every past medication as a flat failure is throwing away half the data.

3. They check whether the diagnosis is complete

Sometimes depression looks treatment-resistant because something underneath it never got named. This is one of the most useful things a re-evaluation can catch, and it is the reason the appointment widens out beyond the depression itself.

Your provider may ask about anxiety, past trauma, attention problems, signs of bipolarity, sleep disorders, chronic pain, alcohol or cannabis use, thyroid function, hormonal shifts, and other medical conditions. This can feel like a detour when you came in to talk about your mood. It is usually the opposite of a detour. If a depression is being held in place by untreated panic, by trauma, by chronically broken sleep, by undiagnosed ADHD, by heavy substance use, or by an unrecognized bipolar pattern, then a third or fourth antidepressant aimed only at the depression is unlikely to solve the real problem. The 2023 World Psychiatry review lists exactly this kind of detection work, and the screening for contributing conditions, as a core part of evaluating apparent resistance rather than an optional add-on.^[1]

4. They ask about safety and how you’re functioning

A real consult also asks how the depression is showing up in your day. Can you work? Are you sleeping and eating? Can you shower, answer messages, keep up with responsibilities, stay in contact with the people who matter to you? Are there thoughts of not being here? Are things getting worse rather than holding steady?

These questions are not a formality, and they are not there to judge you. They set the urgency. Someone who is a little better but still struggling needs one kind of plan and one kind of timeline. Someone who is sliding, or who is no longer safe, needs a faster, higher-support plan that starts now. If you are carrying thoughts of harming yourself, that is not a reason to hold back in the appointment. It is one of the most important things to say out loud, because it moves you to the front of the line. You can also reach the Suicide & Crisis Lifeline any time by calling or texting 988.

5. They decide what actually changes next

After the re-evaluation, the plan should follow from what your history just taught, not from habit. Depending on what the first four steps turned up, the next move might be to adjust the dose of something that was only partially tried, switch to a medication in a different class, add an augmenting agent to a partial response, change or intensify therapy, or treat the sleep, anxiety, trauma, ADHD, or substance use that has been quietly feeding the depression.

And when adequate medication trials genuinely have not been enough, this is the point where the conversation widens to treatments that work differently. The same review names the options with the strongest evidence in treatment-resistant depression: repetitive transcranial magnetic stimulation, which is FDA-cleared for this exact situation; intranasal esketamine and IV ketamine; and electroconvulsive therapy for the more severe end.^[1] TMS has a formal clinical consensus behind its use in depression that has not responded to medication,^[5] and SPRAVATO (esketamine) is FDA-approved for treatment-resistant depression, including, since January 21, 2025, as a standalone treatment rather than only an add-on.^[6] If you want the fuller comparison, we have written about how TMS stacks up against another medication and how to choose between SPRAVATO and TMS.

The plan should never be “keep trying things forever.” It should be a specific next step, chosen because of what the previous steps revealed.

The takeaway

A TRD consult is not an exam you have to pass by proving you are sick enough. It is not about ranking your suffering. It is about building a better map of a problem that has, so far, been navigated mostly in the dark.

When medication has not been enough, the question should never be “what random thing do we try next?” The better questions are the ones a good evaluation is built to answer: what have we actually learned so far, what got missed, and what level of support fits where you are right now? Walk in with even a rough version of your own history, and you turn a vague appointment into a working session. You are not failing treatment. You are finally getting it looked at properly.

By Nefretiri Abat, JD, PMHNP-BC — Founder, Exxceed Wellness, Hayward CA. This article is for general education and does not substitute for individualized medical care. If you are having thoughts of harming yourself, call or text 988 (the Suicide & Crisis Lifeline) or go to your nearest emergency department. Decisions about medication, therapy, and higher-level treatments should be made with a licensed clinician who knows your history.